Aura Biosciences, Inc.AURANASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +30.06% | +11.73% | +1.36% | +17.09% | +32.77% |
| Weighted Average Shares Diluted Growth | +30.06% | +11.73% | +1.36% | +17.09% | +32.77% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +14.23% | -28.45% | -33.88% | -6.36% | -7.46% |
| Book Value per Share Growth | -11.48% | -39.78% | -39.53% | -22.10% | -32.44% |
| Debt Growth | -5.47% | -4.03% | -4.53% | -4.84% | -6.97% |
| R&D Expense Growth | +10.42% | +10.13% | +36.89% | +35.56% | +30.18% |
| SG&A Expenses Growth | +22.45% | +24.00% | +14.87% | -2.58% | -12.40% |